Prudential Financial Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$17.63 - $21.74 $243,294 - $300,012	-13,800 Reduced 8.12%	156,210 $3.08 Million
Q4 2023 Feb 13, 2024	SELL	$14.37 - $19.07 $417,161 - $553,602	-29,030 Reduced 14.59%	170,010 $2.98 Million
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $629,244 - $933,240	46,200 Added 30.23%	199,040 $3.46 Million
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $347,652 - $548,784	33,300 Added 27.86%	152,840 $2.15 Million
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $332,235 - $490,279	31,050 Added 35.09%	119,540 $1.29 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $607,544 - $907,060	53,200 Added 150.75%	88,490 $0
Q3 2022 Nov 04, 2022	BUY	$9.76 - $13.41 $344,430 - $473,238	35,290 New	35,290 $453,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $681M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.